This study is approved for mild and moderate sick

This study is approved for mild and moderate sick , this mean that patient don't need admission to the hospital to receive this treatment..

And that is a good thing.

When we see patient with very mild disease just at the beginning , but with some risk factors , there is no reason to wait.

This virus killing 12-15 days after unset ..and some who survived have permanent damage especially to lungs , but could be other organs , like heart , kidney etc.

I am very happy that we have approval.
I also dislike that double blind study here.

With deadly diseases we often don't see it.
This is why we don't have double blind in our cancers treatment , and this is why they removed it from our GvHD study .

This is so fast progressing disease , I am surprise.
But I am sure doctors will observe all those patients very carefully...



All IMO.